condensed protocol 在学术临床实践中应用 NIA-AA 阿尔茨海默病神经病理评估指南
研究在学术临床神经病理实践中应用简化的 condensed protocol(CP)对 73 例尸检病例进行采样和免疫染色,其中 53 例(72.6%)具有促使 CP 工作的组织学特征。CP 较仅基于临床病史的工作流程增加了 AD 和路易体病神经病理改变的识别,每例节省约 900 美元。研究表明 CP 在临床尸检实践中可行且节约成本,并揭示了普通老龄人群中可能未被识别的神经退行性疾病过程。
要点
- CP 将 NIA-AA 推荐方案整合为更少蜡块和更少免疫组化染色。
- 73 例中 53 例(72.6%)因组织学特征启动 CP 工作流程。
- CP 增加 AD 和路易体病改变识别,每例节省约 900 美元。
核心结论
- CP 在临床尸检实践中可行且节约成本,并揭示普通老龄人群中可能未被识别的神经退行性疾病过程。
研究设计与样本
- 在学术临床神经病理实践中制定启动 CP 采样和免疫染色的实用标准并应用。
- 1 年内采用 CP 采样 73 例,其中 53 例(72.6%)具有促使 CP 工作的组织学特征。
主要发现
- CP 较仅基于临床病史的工作流程增加了 AD 和路易体病神经病理改变的识别。
- CP 每例节省约 900 美元。
关键数值与推荐
- CP 将 NIA-AA 推荐方案整合为更少蜡块和更少免疫组化染色。
- CP 并非替代 NIA-AA 方案,而是使 NIA-AA 标准在资源有限的临床和法医神经病理实践中可及。
临床怎么用
- 在资源有限的临床和法医神经病理实践中,可按实用标准启动 CP 采样和免疫染色。
- CP 有助于在常规尸检中识别 AD 和路易体病等神经退行性改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: In response to concerns regarding resource expenditures required to implement fully the 2012 National Institute on Aging and the Alzheimer's Association (NIA-AA) Sponsored Guidelines for the neuropathological assessment of Alzheimer's disease (AD), we previously developed a sensitive and cost-reducing condensed protocol (CP) at the University of Washington (UW) Alzheimer's Disease Research Center (ADRC) that consolidated the recommended NIA-AA protocol into fewer cassettes requiring fewer immunohistochemical stains. The CP was not designed to replace NIA-AA protocols, but instead to make the NIA-AA criteria accessible to clinical and forensic neuropathology practices where resources limit full implementation of NIA-AA guidelines. METHODS AND RESULTS: In this regard, we developed practical criteria to instigate CP sampling and immunostaining, and applied these criteria in an academic clinical neuropathological practice. During the course of 1 year, 73 cases were sampled using the CP; of those, 53 (72.6%) contained histological features that prompted CP work-up. We found that the CP resulted in increased identification of AD and Lewy body disease neuropathological changes from what was expected using a clinical history-driven work-up alone, while saving approximately $900 per case. CONCLUSIONS: This study demonstrates the feasibility and cost-savings of the CP applied to a clinical autopsy practice, and highlights potentially unrecognised neurodegenerative disease processes in the general ageing community.
引用
- Bharadwaj R, Cimino PJ, Flanagan ME, et al. Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice. Histopathology. 2017. PMID: 28815699. doi:10.1111/his.13345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。